Chinese expert consensus on clinical application of angiotension-neprilysin inhibitor in patients with heart failure.
10.3760/cma.j.cn112148-20211124-01015
- Collective Name:Chinese Society of Cardiology, Chinese Medical Association;Editorial Board of Chinese Journal of Cardiology
- Publication Type:Journal Article
- MeSH:
Aminobutyrates;
Angiotensin Receptor Antagonists;
China;
Consensus;
Drug Combinations;
Heart Failure/drug therapy*;
Humans;
Neprilysin;
Stroke Volume;
Tetrazoles;
Valsartan
- From:
Chinese Journal of Cardiology
2022;50(7):662-670
- CountryChina
- Language:Chinese
